Concepedia

The targeted eosinophil-lowering effects of dexpramipexole in clinical studies

Steven I. Dworetzky, Gregory T. Hebrank, Donald Archibald, Ian J. Reynolds, Wildon Farwell, Michael Bozik

Blood Cells Molecules and Diseases · 2017 · 38 citations · 7 references

DOI

Concepts

References

7

Eosinophilia in transgenic mice expressing interleukin 5.

Lindsay A. Dent, Malcolm Strath, Andrew L. Mellor et al. · The Journal of Experimental Medicine · 1990 · 585 citations · Full text

, , +14

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Merit Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner et al. · The Lancet Neurology · 2013 · 235 citations

, , +8

Distinct myeloid progenitor–differentiation pathways identified through single-cell RNA sequencing

Roy Drissen, Natalija Buza-Vidas, Petter Woll et al. · Nature Immunology · 2016 · 225 citations

, , +12

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis

Merit Cudkowicz, Michael Bozik, Evan W. Ingersoll et al. · Nature Medicine · 2011 · 179 citations

, , +11

Analysis of the Glycan Composition on Plasma Derived ADAMTS13 Employing Tandem Mass Spectrometry

Fabian C. Verbij, Eva Stokhuijzen, Floris van Alphen et al. · Blood · 2015 · 63 citations

, , +12